1,254
Views
5
CrossRef citations to date
0
Altmetric
Original Article

A novel prothrombin time method to measure all non-vitamin K-dependent oral anticoagulants (NOACs)

, , &
Pages 171-176 | Received 27 Mar 2017, Accepted 16 Aug 2017, Published online: 11 Sep 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Andreas Hillarp, Karin Strandberg, Fariba Baghaei, Inger Fagerberg Blixter, Kerstin M. Gustafsson & Tomas L. Lindahl. (2018) Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays. Scandinavian Journal of Clinical and Laboratory Investigation 78:7-8, pages 575-583.
Read now

Articles from other publishers (4)

Liselotte Onelöv, Mojca Božič-Mijovski & Alenka Mavri. (2024) Clot time ratio (CTR) and treatment outcomes in Apixaban-treated atrial fibrillation patients. Scientific Reports 14:1.
Crossref
Liselotte Onelöv, Elvar Theodorsson, Mojca Božič-Mijovski†Alenka Mavri. (2024) Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with Rivaroxaban. Thrombosis Journal 22:1.
Crossref
Orly Efros, Aya Berman, Gili Kenet, Aharon Lubetsky, Alon Doron, Gadi Shlomai, Eyal Klang, Shelly Soffer, Noam Barda & Avshalom Leibowitz. (2024) Elevated International Normalized Ratio and Mortality in Hospitalized Patients Treated with Direct Oral Anticoagulants. The American Journal of Medicine 137:2, pages 147-153.e2.
Crossref
Osamu Kumano, Shinya Suzuki, Masako Yamazaki, Yoshimori An, Masahiro Yasaka & Masahiro Ieko. (2022) Evaluation of newly‐developed modified diluted prothrombin time reagent in non‐valvular atrial fibrillation patients with direct oral anticoagulants: A comparative study with conventional reagents. International Journal of Laboratory Hematology 45:1, pages 119-125.
Crossref